Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rain Oncology Inc
(NQ:
RAIN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.210 (26)
Ask (Size)
1.240 (146)
Prev. Close
1.210
Today's Range
N/A - N/A
52wk Range
0.8200 - 1.255
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pathos AI Completes Acquisition of Rain Oncology
January 26, 2024
From
Pathos AI, Inc.
Via
Business Wire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
January 04, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
More News
Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
January 04, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
December 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
December 18, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
December 18, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
December 14, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
December 14, 2023
From
Halper Sadeh LLC
Via
Business Wire
Rain Oncology Inc. (NASDAQ:RAIN) Long Term Investor Notice: Investigation over Possible Wrongdoing
October 19, 2023
Via
SBWire
Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying
October 16, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
October 13, 2023
Via
Benzinga
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
September 12, 2023
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
September 12, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
September 11, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Via
Benzinga
RAIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
September 08, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – RAIN
September 08, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm
September 06, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
NASDAQ: RAIN Investor Alert: Deadline on September 12, 2023 in Lawsuit Against Rain Oncology Inc.
September 06, 2023
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
September 03, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LEADING NATIONAL FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
September 01, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and Rain and Encourages Investors to Contact the Firm
September 01, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
August 28, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rain, Proterra, and Danaher and Encourages Investors to Contact the Firm
August 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.